Acadian Asset Management LLC Harrow Health, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 4,148 shares of HROW stock, worth $151,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,148
Holding current value
$151,982
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$20.85 - $46.47 $86,485 - $192,757
4,148 New
4,148 $186,000
Q1 2023

May 11, 2023
SELL
$13.84 - $21.46 $1.98 Million - $3.07 Million
-143,162 Reduced 27.92%
369,662 $7.82 Million
Q4 2022

Feb 14, 2023
SELL
$10.28 - $14.78 $324,961 - $467,210
-31,611 Reduced 5.81%
512,824 $7.57 Million
Q3 2022

Nov 14, 2022
SELL
$6.57 - $24.88 $40,865 - $154,753
-6,220 Reduced 1.13%
544,435 $6.57 Million
Q2 2022

Aug 09, 2022
BUY
$5.75 - $7.74 $102,068 - $137,392
17,751 Added 3.33%
550,655 $4.01 Million
Q1 2022

May 12, 2022
SELL
$6.77 - $8.66 $31,385 - $40,147
-4,636 Reduced 0.86%
532,904 $3.63 Million
Q4 2021

Feb 10, 2022
BUY
$8.5 - $12.0 $119,450 - $168,636
14,053 Added 2.68%
537,540 $4.64 Million
Q3 2021

Nov 12, 2021
BUY
$6.99 - $10.6 $305,008 - $462,531
43,635 Added 9.09%
523,487 $4.76 Million
Q2 2021

Aug 11, 2021
BUY
$6.68 - $11.07 $383,472 - $635,484
57,406 Added 13.59%
479,852 $4.46 Million
Q1 2021

May 11, 2021
BUY
$6.26 - $11.03 $187,036 - $329,554
29,878 Added 7.61%
422,446 $2.85 Million
Q4 2020

Feb 11, 2021
BUY
$4.76 - $6.93 $112,878 - $164,338
23,714 Added 6.43%
392,568 $2.69 Million
Q3 2020

Nov 09, 2020
SELL
$4.71 - $7.36 $1.16 Million - $1.81 Million
-246,220 Reduced 40.03%
368,854 $2.06 Million
Q2 2020

Aug 12, 2020
SELL
$3.61 - $6.47 $21,789 - $39,052
-6,036 Reduced 0.97%
615,074 $3.2 Million
Q1 2020

May 11, 2020
SELL
$3.5 - $7.31 $70,388 - $147,011
-20,111 Reduced 3.14%
621,110 $2.37 Million
Q4 2019

Feb 06, 2020
BUY
$4.6 - $7.88 $133,878 - $229,339
29,104 Added 4.75%
641,221 $4.99 Million
Q3 2019

Nov 07, 2019
BUY
$4.89 - $8.0 $251,932 - $412,160
51,520 Added 9.19%
612,117 $3.44 Million
Q2 2019

Aug 08, 2019
BUY
$4.2 - $8.7 $682,327 - $1.41 Million
162,459 Added 40.8%
560,597 $4.88 Million
Q1 2019

May 09, 2019
BUY
$4.75 - $7.1 $1.89 Million - $2.83 Million
398,138 New
398,138 $1.98 Million

Others Institutions Holding HROW

# of Institutions
177
Shares Held
21.4M
Call Options Held
845K
Put Options Held
717K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $992M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email